JEANNE M ENNEGUESS D.O. NPI 1912965369

NPI Details

Jeanne M Enneguess, D.O. is an internal medicine in Peabody, MA with 30 years of experience. The provider is a physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs. Jeanne M Enneguess, D.O. NPI is 1912965369. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a female.

Education
Medical School: UNIVERSITY OF NEW ENGLAND, COLLEGE OF OSTEO MEDICINE
Graduation Year:1995

The provider's business location address is:

2 ESSEX CENTER DR
PEABODY, MA
ZIP 01960-926
Phone: (978) 532-2800
Fax: (978) 977-4491

The NPI 1912965369 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Hemoglobin a1c level (HCPCS:83036)
• Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit (HCPCS:G0439)
• Blood creatinine level (HCPCS:82565)
• Blood test, clotting time (HCPCS:85610)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85027)
• Vitamin d-3 level (HCPCS:82306)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Creatinine level to test for kidney function or muscle injury (HCPCS:82570)
• Urine microalbumin (protein) level (HCPCS:82043)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine split virus, preservative free (HCPCS:90662)
• Blood potassium level (HCPCS:84132)
• Cyanocobalamin (vitamin b-12) level (HCPCS:82607)
• Blood sodium level (HCPCS:84295)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Parathormone (parathyroid hormone) level (HCPCS:83970)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Liver enzyme (sgpt), level (HCPCS:84460)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Calcium level, total (HCPCS:82310)
• Transferrin (iron binding protein) level (HCPCS:84466)
• Iron level (HCPCS:83540)
• Blood test panel for electrolytes (sodium potassium, chloride, carbon dioxide) (HCPCS:80051)
• Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit (HCPCS:G0438)
• Liver function blood test panel (HCPCS:80076)
• Automated urinalysis test (HCPCS:81003)
• Phosphate level (HCPCS:84100)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Blood glucose (sugar) level (HCPCS:82947)
• Urea nitrogen level to assess kidney function, quantitative (HCPCS:84520)
• Albumin (protein) level (HCPCS:82040)
• Bacterial colony count, urine (HCPCS:87086)
• Administration of pneumococcal vaccine (HCPCS:G0009)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Uric acid level, blood (HCPCS:84550)
• Red blood cell sedimentation rate, to detect inflammation, non-automated (HCPCS:85651)
• Measurement c-reactive protein for detection of infection or inflammation (HCPCS:86140)
• Prostate cancer screening; prostate specific antigen test (psa) (HCPCS:G0103)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Bacterial culture for aerobic isolates (HCPCS:87077)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Folic acid level, serum (HCPCS:82746)
• Total protein level, blood (HCPCS:84155)
• Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (HCPCS:87186)
• Pneumococcal vaccine, 23-valent (HCPCS:90732)
• Magnesium level (HCPCS:83735)
• Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment (HCPCS:G0402)

The enumeration date for this NPI number is 5/3/2006 and was last updated on 1/7/2021.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.